canrenone has been researched along with 17-alpha-hydroxyprogesterone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felber, JP; Locatelli, L; Ramelet, AA; Rey, FO; Valterio, C | 1 |
1 trial(s) available for canrenone and 17-alpha-hydroxyprogesterone
| Article | Year |
|---|---|
Lack of endocrine systemic side effects after topical application of spironolactone in man.
Topics: 17-alpha-Hydroxyprogesterone; Administration, Topical; Adult; Androgens; Androstane-3,17-diol; Canrenone; Endocrine Glands; Humans; Hydroxyprogesterones; Male; Salivary Glands; Spironolactone; Testosterone | 1988 |